-
1
-
-
49849088979
-
Anemia and mortality in heart failure patients: A systematic review and meta-analysis
-
H.F. Groenveld, J.L. Januzzi, and K. Damman Anemia and mortality in heart failure patients: a systematic review and meta-analysis J Am Coll Cardiol 52 2008 818 827
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 818-827
-
-
Groenveld, H.F.1
Januzzi, J.L.2
Damman, K.3
-
2
-
-
33846669860
-
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: A meta-analysis
-
A. Phrommintikul, S.J. Haas, M. Elsik, and H. Krum Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis Lancet 369 2007 381 388
-
(2007)
Lancet
, vol.369
, pp. 381-388
-
-
Phrommintikul, A.1
Haas, S.J.2
Elsik, M.3
Krum, H.4
-
3
-
-
70949108082
-
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
-
M.A. Pfeffer, E.A. Burdmann, and C.Y. Chen A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2009 2019 2032
-
(2009)
N Engl J Med
, vol.361
, pp. 2019-2032
-
-
Pfeffer, M.A.1
Burdmann, E.A.2
Chen, C.Y.3
-
4
-
-
33845225092
-
Protective effects of erythropoietin in cardiac ischemia: From bench to bedside
-
E. Lipsic, R.G. Schoemaker, P. van der Meer, A.A. Voors, D.J. van Veldhuisen, and W.H. van Gilst Protective effects of erythropoietin in cardiac ischemia: from bench to bedside J Am Coll Cardiol 48 2006 2161 2167
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 2161-2167
-
-
Lipsic, E.1
Schoemaker, R.G.2
Van Der Meer, P.3
Voors, A.A.4
Van Veldhuisen, D.J.5
Van Gilst, W.H.6
-
5
-
-
24644520622
-
Expression of the erythropoietin receptor in human heart
-
R. Depping, K. Kawakami, and H. Ocker Expression of the erythropoietin receptor in human heart J Thorac Cardiovasc Surg 130 2005 877 878
-
(2005)
J Thorac Cardiovasc Surg
, vol.130
, pp. 877-878
-
-
Depping, R.1
Kawakami, K.2
Ocker, H.3
-
6
-
-
8844247185
-
Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury
-
P. van der Meer, E. Lipsic, and R.H. Henning Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury Eur J Heart Fail 6 2004 853 859
-
(2004)
Eur J Heart Fail
, vol.6
, pp. 853-859
-
-
Van Der Meer, P.1
Lipsic, E.2
Henning, R.H.3
-
7
-
-
37549020370
-
Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit
-
E. Lipsic, B.D. Westenbrink, and P. van der Meer Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit Eur J Heart Fail 10 2008 22 29
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 22-29
-
-
Lipsic, E.1
Westenbrink, B.D.2
Van Der Meer, P.3
-
8
-
-
0024497455
-
Survival of recombinant erythropoietin in the circulation: The role of carbohydrates
-
M.N. Fukuda, H. Sasaki, L. Lopez, and M. Fukuda Survival of recombinant erythropoietin in the circulation: the role of carbohydrates Blood 73 1989 84 89
-
(1989)
Blood
, vol.73
, pp. 84-89
-
-
Fukuda, M.N.1
Sasaki, H.2
Lopez, L.3
Fukuda, M.4
-
9
-
-
33746137372
-
Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise
-
M. Brines, and A. Cerami Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise Kidney Int 70 2006 246 250
-
(2006)
Kidney Int
, vol.70
, pp. 246-250
-
-
Brines, M.1
Cerami, A.2
-
10
-
-
0037974734
-
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
-
S. Erbayraktar, G. Grasso, and A. Sfacteria Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo Proc Natl Acad Sci U S A 100 2003 6741 6746
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 6741-6746
-
-
Erbayraktar, S.1
Grasso, G.2
Sfacteria, A.3
-
11
-
-
34548155283
-
Asialoerythropoietin has strong renoprotective effects against ischemia-reperfusion injury in a murine model
-
T. Okada, T. Sawada, and K. Kubota Asialoerythropoietin has strong renoprotective effects against ischemia-reperfusion injury in a murine model Transplantation 84 2007 504 510
-
(2007)
Transplantation
, vol.84
, pp. 504-510
-
-
Okada, T.1
Sawada, T.2
Kubota, K.3
-
12
-
-
78649376254
-
Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia
-
A. Ogino, G. Takemura, and M. Kawasaki Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia J Am Coll Cardiol 56 2010 1949 1958
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 1949-1958
-
-
Ogino, A.1
Takemura, G.2
Kawasaki, M.3
-
13
-
-
1042286928
-
The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: The role of microvascular growth and abnormalities
-
R.A. De Boer, Y.M. Pinto, and D.J. Van Veldhuisen The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities Mircocirculation 10 2003 113 126
-
(2003)
Mircocirculation
, vol.10
, pp. 113-126
-
-
De Boer, R.A.1
Pinto, Y.M.2
Van Veldhuisen, D.J.3
-
14
-
-
21344459065
-
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction
-
P. van der Meer, E. Lipsic, and R.H. Henning Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction J Am Coll Cardiol 46 2005 125 133
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 125-133
-
-
Van Der Meer, P.1
Lipsic, E.2
Henning, R.H.3
-
15
-
-
34848832453
-
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization
-
B.D. Westenbrink, E. Lipsic, and P. van der Meer Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization Eur Heart J 28 2007 2018 2027
-
(2007)
Eur Heart J
, vol.28
, pp. 2018-2027
-
-
Westenbrink, B.D.1
Lipsic, E.2
Van Der Meer, P.3
-
16
-
-
37549028422
-
Asialoerythropoietin is a strong modulator of angiogenesis by bone-marrow cells
-
S. Mori, T. Sawada, and K. Kubota Asialoerythropoietin is a strong modulator of angiogenesis by bone-marrow cells J Invest Surg 20 2007 357 362
-
(2007)
J Invest Surg
, vol.20
, pp. 357-362
-
-
Mori, S.1
Sawada, T.2
Kubota, K.3
-
17
-
-
6944237300
-
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor
-
M. Brines, G. Grasso, and F. Fiordaliso Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor Proc Natl Acad Sci U S A 101 2004 14907 14912
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 14907-14912
-
-
Brines, M.1
Grasso, G.2
Fiordaliso, F.3
-
18
-
-
13844320400
-
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury
-
F. Fiordaliso, S. Chimenti, and L. Staszewsky A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury Proc Natl Acad Sci U S A 102 2005 2046 2051
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 2046-2051
-
-
Fiordaliso, F.1
Chimenti, S.2
Staszewsky, L.3
|